Indeed, as previously reported in the published researches,42, 56 the outcomes of stratified analysis demonstrated that cfDNA from plasma had higher diagnostic accuracy than that from serum, suggesting that cfDNA in plasma may perform better in detecting KRAS status in CRC individuals. This evidence concerns the gene KRAS and colorectal carcinoma.